[HTML][HTML] Review of current treatment intensification strategies for prostate cancer patients

S Wasim, J Park, S Nam, J Kim - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer (PCa) affects millions of men worldwide, and the mortality
rate for locally advanced or metastasized cancer cases remains high. Despite the …

[HTML][HTML] Gastrointestinal/genitourinary adverse event after intensity modulated versus three-dimensional primary radiation therapy in the treatment of prostate cancer …

W Guo, YC Sun, LY Zhang, XM Yin - Journal of Cancer, 2023 - ncbi.nlm.nih.gov
Objective: Prostate cancer (PCa) is one of the most common cancers in the world. The
potential benefits of intensity modulated radiation therapy (IMRT) over three-dimensional …

Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer

A Strusi, G Pinterpe, C Ciccarese… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT The 2024 ASCO Genitourinary Cancer Symposium, this year celebrating the
20th anniversary, delved into key advancements in urothelial carcinoma (UC) and prostate …

Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis

O Mohamad, L Nicosia, E Mathier, E Riggenbach… - Brachytherapy, 2024 - Elsevier
PURPOSE In this systematic review and meta-analysis, we describe the oncologic and
toxicity outcomes of definitive focal brachytherapy for prostate cancer. METHODS AND …

Interpretation of wide confidence intervals in meta-analytic estimates: Is the′ Absence of Evidence′′ Evidence of Absence′?

SL Miller, J Tuia, V Prasad - medRxiv, 2023 - medrxiv.org
Introduction: Recently, a Cochrane review by Jefferson et al. on physical interventions to
slow the spread of respiratory viruses concluded that,″Wearing masks in the community …